Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

HSE National Clinical Guideline: Diagnosis and staging of patients with Prostate Cancer


Topic: Prostate cancer
Document Owner: Head of evidence and quality hub, national cancer control programme (nccp)
National Group: National cancer control programme
Effective From: 15 January 2025
Evidence-based recommendations on the diagnosis and staging of patients with prostate cancer

The purpose of this National Clinical Guideline is to provide evidence based recommendations on the diagnosis and staging of patients with prostate cancer through the integration of the best research evidence with clinical expertise, patient values and experiences.